Researchers See Chance U.S. Might Pull COX-2 Drugs
627905
Doctors who led three studies  showing prescription painkillers called COX-2 inhibitors raise  the risk of heart attacks and stroke said on Tuesday the whole  class of drugs was in danger of being pulled from the market.
151727
Two Boston doctors are cautioning physicians to prescribe pain relievers called cox-2 inhibitors such as Celebrex only as a last resort in patients at risk for heart attacks.
373977
Two studies released yesterday have turned up new evidence that all of the popular arthritis painkillers known as cox-2 inhibitors may put users at greater risk of heart attacks and strokes.
387871
Oct. 6, 2004 - Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
216531
Consumers can be excused if the Cox 2 painkiller debacle has left them scratching their heads. First, Merck (MRK ) pulled its Vioxx off the market after a study confirmed suspicions that it was linked to an increased risk of heart attack and stroke.
601140
For millions of Americans, the latest news is a great big pain in the neck, or maybe it&#39;s the shoulder. The Big Three of anti-inflammatory drugs - Vioxx, Celebrex and now Aleve - are believed to be potential health risks for patients.
449178
US regulators warned yesterday of possible heart risks with Pfizer&#39;s Bextra, delivering another blow to popular pain drugs cox-2 inhibitors such as Vioxx, withdrawn from the market by Merck in September.
652888
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month's worldwide withdrawal of Merck & Co Inc.'s Vioxx.
108052
AS more skeletons tumble out of the cupboard, globally, on the safety of the Cox II family of anti-inflammatory drugs, Indian regulatory authorities too are not taking a chance.
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
116111
After alarming news about popular painkillers like Celebrex and Vioxx, an American study is pointing to another way to control the pain of arthritis.
34608
GAITHERSBURG, Md.  - U.S. scientific advisers  began hearing evidence on Wednesday about the benefits and  risks of pain killers taken by millions of Americans as  regulators weigh moves following Merck & Co. Inc.'s recall of  its arthritis pill Vioxx.
315794
While researchers plan to look at the use of all NSAIDs in clinical trials, people shouldn&#39;t take high doses or for too long. By Amanda Gardner.
339251
BOSTON - The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
54816
Medicines used by millions of  Americans to relieve aches and pains will come under intense  scrutiny starting Wednesday as U.S. scientists scour dozens of  studies to determine if the drugs risk damaging the heart like  Merck & Co. Inc.'s MRK.N withdrawn arthritis pill Vioxx.
272490
The US Food and Drug Administration is recommending physicians limit prescriptions for popular painkillers known as Cox-2 inhibitors after recent studies suggested they may increase the risk of heart attacks and strokes.